"When it finally gets warm, it's going to explode." Expert warns about impending allergy season: 'It's going to be really bad ...
A string of FDA approvals and late-stage clinical trials has expanded the toolkit for treating seasonal and environmental ...
GSK (LSE:GSK) has completed its acquisition of RAPT Therapeutics, securing global rights to key immunology assets. The deal brings ozureprubart, a monoclonal antibody for severe food allergies, into ...